Clinical factors related to long-term administration of sorafenib in patients with hepatocellular carcinoma.
Nojiri S, Kusakabe A, Fujiwara K, Shinkai N, Matsuura K, Iio E, Miyaki T, Nomura T, Sobue S, Sano H, Hasegawa I, Ohno T, Takahashi Y, Orito E, Joh T.
Nojiri S, et al. Among authors: shinkai n.
Cancer Manag Res. 2012;4:423-9. doi: 10.2147/CMAR.S38684. Epub 2012 Dec 18.
Cancer Manag Res. 2012.
PMID: 23293537
Free PMC article.